Burning Rock Biotech (FRA:6BU0) Float Percentage Of Total Shares Outstanding: 0.00% (As of Jul. 12, 2026)


FRA:6BU0 Burning Rock Biotech Ltd FRA:6BU0
62 GF Score
Price €9.10
GF Value €8.99
Valuation Fairly Valued
! 2 Warning Signs
View Full Analysis

What is Burning Rock Biotech Float Percentage Of Total Shares Outstanding?

Burning Rock Biotech FRA:6BU0 -9.00% 62 Float Percentage Of Total Shares Outstanding is 0.00% as of Jul. 12, 2026. GuruFocus rates FRA:6BU0 with a GF Score™ of 62/100 and a GF Value™ of €8.99 (Fairly Valued). The stock has 2 warning signs investors should review.

Float percentage of total shares outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Burning Rock Biotech's float shares is 0.00 Mil. Burning Rock Biotech's total shares outstanding is 10.55 Mil. Burning Rock Biotech's float percentage of total shares outstanding is 0.00%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Burning Rock Biotech's Insider Ownership is 0.00%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Burning Rock Biotech's Institutional Ownership is 0.53%.

FRA:6BU0
62GF Score
Burning Rock Biotech Ltd FRA:6BU0
Float Percentage Of Total Shares Outstanding is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Burning Rock Biotech Float Percentage Of Total Shares Outstanding Calculation

It is the percentage of float shares out of the total shares outstanding.

Burning Rock Biotech's Float Percentage of Total Shares Outstanding for today is calculated as follows:

Float Percentage of Total Shares Outstanding=Float Shares/Total Shares Outstanding
=0.00/10.55
=0.00%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Float Percentage Of Total Shares Outstanding of 0.00% mean?
Burning Rock Biotech (FRA:6BU0) has a Float Percentage Of Total Shares Outstanding of 0.00% as of Jul. 12, 2026. Float percent of shares outstanding equals the percent of float shares relative to total shares. View historical data on Burning Rock Biotech and its competitors.
Is Burning Rock Biotech's Float Percentage Of Total Shares Outstanding too high?
Burning Rock Biotech's current Float Percentage Of Total Shares Outstanding is 0.00%. Overall, Burning Rock Biotech has a GF Score™ of 62/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Burning Rock Biotech's Float Percentage Of Total Shares Outstanding compare to XGN and IDXG?
Burning Rock Biotech's Float Percentage Of Total Shares Outstanding of 0.00% can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Float Percentage Of Total Shares Outstanding for a Medical Diagnostics & Research company?
A good Float Percentage Of Total Shares Outstanding depends on the Medical Diagnostics & Research industry context. However, Float Percentage Of Total Shares Outstanding should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Float Percentage Of Total Shares Outstanding mean?
A high Float Percentage Of Total Shares Outstanding can signal that a stock is expensive relative to its fundamentals. Float percent of shares outstanding equals the percent of float shares relative to total shares. View historical data on Burning Rock Biotech and its competitors. Burning Rock Biotech's current Float Percentage Of Total Shares Outstanding is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Burning Rock Biotech stock overvalued right now?
Based on GuruFocus' analysis, Burning Rock Biotech (FRA:6BU0) is currently considered Fairly Valued. The stock's GF Value™ is €8.99, compared to a current price of €9.10 — trading 1.2% above its estimated fair value. The current Float Percentage Of Total Shares Outstanding is 0.00%. Burning Rock Biotech's overall GF Score™ is 62/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Float Percentage Of Total Shares Outstanding calculated?
Float Percentage Of Total Shares Outstanding is calculated from a company's financial statements. For Burning Rock Biotech (FRA:6BU0), the current Float Percentage Of Total Shares Outstanding is 0.00% as of Jul. 12, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Burning Rock Biotech (FRA:6BU0) Overvalued in 2026?

Based on GuruFocus' analysis, Burning Rock Biotech stock appears to be overvalued. The current stock price of €9.10 is trading 1.2% above its estimated GF Value™ of €8.99. GuruFocus considers Burning Rock Biotech to be Fairly Valued.

Key valuation signals for FRA:6BU0:

  • Float Percentage Of Total Shares Outstanding: 0.00%
  • GF Value™: €8.99 vs. price of €9.10 (1.2% above fair value)
  • GF Score™: 62/100 with 2 warning signs

No single metric tells the full story. See the FRA:6BU0 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Burning Rock Biotech Business Description

Other Exchanges BNR:USA
Address No. 5, Xingdao Ring Road North, International Bio Island, Guangzhou, CHN, 510005
Burning Rock Biotech Ltd is a cancer diagnostics company. The Group provides pharma research and development services, mainly cancer therapy selection tests services, companion diagnostics development services, and other service agreements with the combination of various customized tests services and analytical validation services, to pharmaceutical companies for developing new drugs for targeted therapies, immunotherapies on various types of cancers, and to hospitals for their studies on cancer diagnosis & treatment. It had three operating segments, including the Central laboratory business, the In-hospital business, & Pharma research & development services. It generates the majority of its revenue from the Central laboratory business. Its products are Pan-HEME, OncoScreen-WES, & others.
62GF Score

Get the complete analysis for FRA:6BU0

Float Percentage Of Total Shares Outstanding is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€9.10
Price
€8.99
GF Value